Online citations, reference lists, and bibliographies.

Calcium Citrate And Vitamin D In The Treatment Of Osteoporosis

J. M. Q. Gómez, J. B. Rubió, M. D. Curiel, A. Pérez
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The combination of calcium with vitamin D (vitamin D3 [colecalciferol]) forms the basis of preventive and therapeutic regimens for osteoporosis. A number of studies have suggested that the combination of calcium and vitamin D is effective when administered at respective dosages of at least 1200 mg and 800IU per day, although efficacy is, as expected, affected by patient compliance. Overall, treatment with this combination appears to be effective in reducing the incidence of non-vertebral and hip fractures. Also, in all drug studies (of antiresorptive and anabolic agents and strontium ranelate) that demonstrated a reduction in risk of osteoporotic fractures, patients also took calcium and vitamin D supplements. An important finding in this regard is that vitamin D levels have been demonstrated to be inadequate in more than half of women treated for osteoporosis in the US and Europe.The capacity of the small intestine to absorb calcium salts depends on the solubility and ionization of the salts. These properties vary for different salts, with fasting calcium citrate absorption being greater than that of calcium lactogluconate and calcium carbonate. Calcium citrate formulations taken between meals may help to prevent abdominal distension and flatulence, as well as minimize the risk of renal calculus formation, thus helping to optimize patient compliance. Therefore, calcium citrate combined with vitamin D is the combination of choice for the prevention or treatment of osteoporosis.
This paper references
10.1080/07315724.2001.10719038
Absorbability and Cost Effectiveness in Calcium Supplementation
R. Heaney (2001)
10.1136/bmj.330.7498.1003
Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care
Jill Porthouse (2005)
10.1503/cmaj.071330
Use of proton pump inhibitors and risk of osteoporosis-related fractures
L. Targownik (2008)
10.1007/s00223-004-0005-4
Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis
F. Richy (2004)
10.1093/ajcn/48.5.1291
Calcium absorption from calcium carbonate and a new form of calcium (CCM) in healthy male and female adolescents.
J. Miller (1988)
10.1056/NEJMOA022436
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
P. Meunier (2004)
10.1079/BJN/2002534
Calcium intake, calcium bioavailability and bone health.
K. Cashman (2002)
10.1111/j.1532-5415.1986.tb03985.x
Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.
S. Krasinski (1986)
10.1056/NEJM198507113130202
Calcium absorption and achlorhydria.
R. Recker (1985)
10.1016/S0140-6736(05)63013-9
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.
A. Grant (2005)
10.5860/choice.29-5466
The Essential Guide to Vitamins and Minerals
E. Somer (1991)
10.1056/NEJM199005033221803
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
T. Storm (1990)
10.1210/JC.2004-2364
Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy
M. Holick (2005)
10.7326/0003-4819-146-5-200703060-00005
Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis
S. Greenspan (2007)
10.1172/JCI113283
Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium.
M. Sheikh (1988)
10.1056/NEJMRA050100
Adherence to medication.
L. Osterberg (2005)
10.1016/S1701-2163(16)32087-4
Canadian Consensus Conference on osteoporosis, 2006 update.
J. Brown (2006)
10.1016/S0140-6736(07)61342-7
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis
B. Tang (2007)
10.1136/jcp.54.1.54
Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study
C. Williams (2001)
10.1001/JAMA.280.24.2077
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.
S. Cummings (1998)
10.1056/NEJM199709043371003
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
B. Dawson-Hughes (1997)
Osteoporosis prevention, diagnosis, and therapy.
A. Klibanski (2000)
10.1001/JAMA.282.14.1344
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
S. Harris (1999)
10.7326/0003-4819-66-5-917
The absorption of calcium carbonate.
P. Ivanovich (1967)
10.1359/JBMR.2002.17.4.709
Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial.
H. Meyer (2002)
10.1007/BF02556676
Calcium absorption from a new calcium delivery system (CCM)
K. T. Smith (2007)
10.7326/0003-4819-124-4-199602150-00003
Vitamin D Supplementation and Fracture Incidence in Elderly Persons
P. Lips (1996)
10.1001/JAMA.293.18.2257
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.
H. Bischoff-Ferrari (2005)
10.1007/s00198-006-0073-6
Determinants of adherence to osteoporosis treatment in clinical practice
M. Rossini (2006)
10.1210/JC.2006-1404
Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials.
S. Boonen (2007)
10.1210/JC.2004-1774
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
J. Reginster (2005)
10.1001/JAMA.291.16.1999
Effect of Vitamin D on falls: a meta-analysis.
H. Bischoff-Ferrari (2004)
10.1002/JBMR.5650030303
Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate.
J. Harvey (1988)
10.1002/14651858.cd000227.pub3
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
A. Avenell (2005)
10.1159/000116623
Minireview on Regulation of Intestinal Calcium Absorption
A. Pérez (2008)
10.1007/s00223-008-9148-z
Suppression of Parathyroid Hormone and Bone Resorption by Calcium Carbonate and Calcium Citrate in Postmenopausal Women
S. D. Thomas (2008)
10.1007/s001980200023
Combined Calcium and Vitamin D3 Supplementation in Elderly Women: Confirmation of Reversal of Secondary Hyperparathyroidism and Hip Fracture Risk: The Decalyos II Study
M. C. Chapuy (2002)
10.1093/JN/134.11.3137
Vitamin D and the dual processes of intestinal calcium absorption.
R. Wasserman (2004)
10.1172/JCI113886
Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
M. Sheikh (1989)
10.1503/cmaj.080873
Proton pump inhibitors: balancing the benefits and potential fracture risks
J. Richards (2008)
10.1016/S0002-9343(00)00490-3
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
C. Chesnut (2000)
10.1007/BF01623832
Acute biochemical variations induced by four different calcium salts in healthy male volunteers
J. Reginster (2005)
10.1138/20050160
The relation between serum calcidiol and calcitriol
B. Nordin (2005)
10.1007/s00223-006-0021-7
Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture
P. Vestergaard (2006)
10.1080/07315724.1990.10720413
Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting.
J. Harvey (1990)
10.1210/jcem-61-2-391
Calcium bioavailability from calcium carbonate and calcium citrate.
M. Nicar (1985)
10.1056/NEJMOA055218
Calcium plus vitamin D supplementation and the risk of fractures.
R. Jackson (2006)
10.1007/s001980050010
Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
J. Reginster (2000)
10.1093/ajcn/80.6.1689S
Overview of general physiologic features and functions of vitamin D.
H. DeLuca (2004)
10.1159/000177811
Iron status of a healthy French population: factors determining biochemical markers.
P. Preziosi (1994)
10.1359/JBMR.040325
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
C. Chesnut (2004)
10.1093/ajcn/53.1.112
Calcium: effect of different amounts on nonheme- and heme-iron absorption in humans.
L. Hallberg (1991)
10.1001/JAMA.282.7.637
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
B. Ettinger (1999)
10.1056/NEJM200102013440503
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
M. Mcclung (2001)
Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91.
K. Alaimo (1994)
10.1016/S0022-5347(17)32730-1
Limited risk of kidney stone formation during long-term calcium citrate supplementation in nonstone forming subjects.
K. Sakhaee (1994)
10.1097/01.JU.0000136400.14728.CD
Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
K. Sakhaee (2004)
10.1001/ARCHINTE.166.4.424
Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial.
H. Bischoff-Ferrari (2006)
Intake of calcium and vitamin D by the Pyrenean population
J. González-Bonillo (1997)
10.1136/bmj.326.7387.469
Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial
D. Trivedi (2003)
10.1016/S0140-6736(96)07088-2
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
D. Black (1996)
10.1152/PHYSREV.00003.2004
Calcium absorption across epithelia.
J. Hoenderop (2005)
10.1111/J.1365-2796.2006.01685.X
The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation.
P. Lips (2006)
10.1001/JAMA.296.24.2947
Long-term proton pump inhibitor therapy and risk of hip fracture.
Yu-Xiao Yang (2006)
10.1097/00045391-199911000-00005
Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate.
K. Sakhaee (1999)
10.1001/JAMA.1997.03550080069041
Gastric acidity in older adults.
A. Hurwitz (1997)
10.1093/ajcn/53.1.106
Calcium supplementation: effect on iron absorption.
J. Cook (1991)
10.1111/j.1445-5994.1986.tb01147.x
The acute biochemical effects of four proprietary calcium preparations.
I. Reid (1986)
10.1056/NEJMOA067312
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
D. Black (2007)
10.1111/j.1742-1241.2006.01059.x
Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study*
A. Cooper (2006)
Longitudinal changes in the intake of vitamins and minerals of elderly Europeans. SENECA Investigators.
J. A. Amorim Cruz (1996)
10.1007/BF01623661
Comparison of the biochemical and hormonal acute effects of calcium salts.
S. Guillemant (1995)
10.1056/NEJM199212033272305
Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women
M. Chapuy (1992)
10.1007/s00223-001-0032-3
The Importance of Calcium Intake For Lifelong Skeletal Health
R. Heaney (2002)
10.1210/ER.2001-8002
VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women
E. Papadimitropoulos (2002)
10.1056/NEJM200105103441904
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
R. Neer (2001)
10.1007/s00198-008-0650-y
Vitamin D status and response to treatment in post-menopausal osteoporosis
S. Adami (2008)
10.1001/jama.1994.03520240070044
Optimal calcium intake.
R. Heaney (1995)
10.1093/ajcn/60.4.592
Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis.
B. Levine (1994)
10.1007/s001980050111
Absorption of Calcium as the Carbonate and Citrate Salts, with Some Observations on Method
R. Heaney (1999)
10.1172/JCI111254
An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium.
G. Bo-Linn (1984)
10.1016/J.AMJMED.2005.02.007
Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.
M. B. O'Connell (2005)
10.1185/030079905X61875
Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis*
J. Cramer (2005)
10.1007/BF01623012
Intestinal calcium absorption from different calcium preparations: Influence of anion and solubility
C. Hansen (2005)
10.1007/S00394-005-0549-8
On the opinion of the European Commission “Scientific Committee on Food” regarding the tolerable upper intake level of vitamin E (2003)
A. Azzi (2005)
10.2165/00002512-200522080-00003
Effect of Age-Related Changes in Gastric Physiology on Tolerability of Medications for Older People
J. Newton (2005)
10.1016/B978-0-12-415853-5.00028-5
Nutrition and Risk for Osteoporosis
Robert Proulx Heaney (2013)
10.1177/009127000004001108
Pharmacokinetic and pharmacodynamic comparison of two calcium supplements in postmenopausal women.
H. Heller (2000)
10.7326/0003-4819-132-5-200003070-00003
Low Fractional Calcium Absorption Increases the Risk for Hip Fracture in Women with Low Calcium Intake
K. Ensrud (2000)
10.1056/NEJMC060763
Calcium plus vitamin D and the risk of fractures.
Susan Terris (2006)
10.1007/BF02430530
Relation between gastric secretion of acid and urinary excretion of calcium after oral supplements of calcium
J. N. Hunt (1983)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar